CervoMed (CRVO) Acquisitions (2010 - 2011)
CervoMed (CRVO) posted Acquisitions of -$502127.0 for Q4 2011, down 2827.77% sequentially from $18408.0 in Q3 2011, and down 176.31% YoY from $658015.0 in Q4 2010.
CervoMed (CRVO) Acquisitions (2010 - 2011) Analysis & Trends
CervoMed has reported Acquisitions for 2 years, with the latest figure at -$502127.0 in Q4 2011.
- Quarterly Acquisitions fell 176.31% year-over-year to -$502127.0 in Q4 2011, while the trailing twelve-month figure through Dec 2011 was $314236.0 (changed N/A YoY) and the FY2011 annual result came in at $358768.0, down 73.83% from the prior year.
- Acquisitions retreated to -$502127.0 in Q4 2011 per CRVO's latest filing, from $18408.0 in the prior quarter.
- Over five years, Acquisitions peaked at $658015.0 in Q4 2010 and troughed at -$502127.0 in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | CervoMed | 26.12 Mn | 26.12 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | -502,127.00 |
| Sep 30, 2011 | 18,408.00 |
| Dec 31, 2010 | 658,015.00 |
| Sep 30, 2010 | 139,940.00 |